Christopher Donnelly, PhD
Chris is an Assistant Professor in the Department of Neurobiology at the University of Pittsburgh School of Medicine and Scientific Director of the LiveLikeLou Center for ALS Research in the University of Pittsburgh Brain Institute.
Originally from Philadelphia, PA, Chris completed his B.S. in Biosciences at Drexel University in 2005 and received his Ph.D. in Molecular Biology and Genetics at the University of Delaware in 2011.
Chris completed his postdoctoral work at Johns Hopkins University in 2015 where he studied ALS/FTD using induced pluripotent stem cell neurons from patients and published one of the first studies to test antisense oligonucleotide therapeutics in C9orf72 ALS/FTD (currently in clinical trials) and identified nucleocytoplasmic transport dysfunction in ALS/FTD. Chris moved to University of Pittsburgh School of Medicine in 2015 and opened his lab in the LiveLikeLou Center for ALS Research.